According to Lipocine's latest financial reports the company's current EPS (TTM) is -HK$17.15. In 2022 the company made an earnings per share (EPS) of -HK$15.75 a decrease over its 2021 EPS that were of -HK$1.32.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$17.33 | 10% |
2022 | -HK$15.75 | 1094.12% |
2021 | -HK$1.32 | -97.5% |
2020 | -HK$52.77 | -20% |
2019 | -HK$65.96 | -9.09% |
2018 | -HK$72.56 | -47.12% |
2017 | -HK$137.20 | -0% |
2016 | -HK$137.20 | -4.93% |
2015 | -HK$144.32 | -31.63% |
2014 | -HK$211.07 | 74.47% |
2013 | -HK$120.98 | -99.35% |
2012 | -HK$18,563 |